Articles On Volpara Health Technologies (ASX:VHT)

The Australian life sciences sector hasn’t had a good run in the past year. While the S&P/ASX 200 is up ~8%, the S&P/ASX 200 healthcare index has fallen ~2%.  However, Morgans senior analyst from the healthcare team Scott Power is c...

ASX posts 0.5% gain on Thursday Small caps retreat as commodities tread water US stocks futures pointing ~0.9% higher The resources heavy ASX Emerging Companies (XEC) index is down about 0.5% on Thursday, with both oil and the major commo...

Some ASX shares are displaying rampant growth. Despite that, there are a number that have fallen heavily in recent times. While a lower share price doesn’t mean a business is necessarily better value, it does mean that the market capitalis...

Volpara Health Technologies (VHT) makes changes to its leadership team to support its next phase of growth and innovation Dr Ralph Highnam will be transitioning to Chief Science and Innovation Officer after 13 years as Group CEO, and will...

Volpara Health Technologies (ASX:VHT) has announced changes to its board and leadership team in a move it says is designed to support its next phase of growth.

Experts have named some ASX shares as buys, and April 2022 could be the time to jump on these opportunities. When a business generates a lot of revenue growth, it could lead to elevated compound growth over time. Here are two ASX shares th...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. Good news for coffee lovers, particularly those w...

I think that in periods of uncertainty and volatility, high-quality ASX shares could be the way to go. Quality could mean different things to different people. It could mean great management. Quality could mean the resilience of earnings. I...

ASX biotech shares have, as a whole, had a remarkably poor run over the last 6 months. Here’s what we mean. Over the past 6 months, the All Ordinaries Index (ASX: XAO) is down 2.2%. Not what you’d like to see. But not close to gut wrenchin...

There are some outstanding ASX tech shares that I would like to buy for my portfolio. During these times of severe volatility, mostly declines, some excellent opportunities are opening up for investors. A business isn’t a buy just because i...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Through the destruction of war...

The ASX share market continues to be volatile, which gives investors the opportunity to buy ASX growth shares at cheaper prices. Businesses that are still growing revenue whilst the share price falls could be an idea for investors to look...

Shares in Volpara Health Technologies Ltd (ASX: VHT) finished trading on Thursday up 4.51% in the green at 70 cents. Investors appeared to be reacting positively to a company announcement from Volpara today. Even though the release wasn’t...

Plenty of ASX healthcare shares fell to 52-week lows today. The industry has not been immune to the ASX share market selloff. There is ongoing volatility with investors keeping an on the Russian conflict with Ukraine, the sanctions and the...

This year has already seen a lot of volatility on the ASX share market. Some ASX tech shares have fallen more than 30% since the start of 2022. Lower prices for businesses may not necessarily mean that they are better value. But, it could...

In this week’s ScoPo’s Powerplays, healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, examines the turbulent start to 2022 for ASX health stocks and what could lie ahead as ge...

The ASX 200 (ASX: XJO) share market has had a very volatile start to the year. The situation that’s occurring in Ukraine is horrific. What are investors meant to do about these types of events? Stay calm It’s terrible what the people of Ukr...

Every growth investor should want to know about the two ASX shares in this article. A decade ago, some of the ASX’s current blue chip ASX growth shares were much smaller and have gone through a long growth journey to get to where they are...

I really like the look of some high-quality ASX shares that have the potential to create solid long-term returns. There is a lot more volatility this year as investor fears appear to be rising when it comes to interest and inflation. These...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Everyone loves a comeback. Just...

If you’re an investor with a high tolerance for risk, then you may want to look at the ASX shares listed below. This week the team at Bell Potter put speculative buy ratings on them. Here’s what you need to know: Bubs Australia Ltd (ASX:...

Medtech Volpara has delivered another strong quarter of growth as it continues to advance its position in the growing personalised medicine sector. Healthcare technology company Volpara (ASX:VHT) has reported quarterly cash receipts of NZ$...

Key points There are some high-quality ASX tech shares that have been sold-off, which could be opportunities Doctor Care Anywhere, a telehealth business, is seeing a strong increase in organic revenue and growing its number of patients Vo...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. During his Australian Open quar...

Are you looking to add a small cap share or two to your portfolio in the near future? If you are, then you might want to consider one of the ASX shares listed below. Here’s what you need to know about these exciting small cap shares: Alcid...

Healthcare and life sciences expert Scott Power,who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. The Australian Open has kicked o...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

ShareCafeVHT – Morgans rates the stock as Add Morgans believes there is value (unrecognised by the market) in Volpara Health Technologies’ data set (51m images) that could be worth up to $100m. The broker adopts a changed valuation method a...

A wide array of different ASX growth shares have been sold off in recent weeks and months. It looks to me like they’re on sale. I think that the weakness of many different share prices looks like a good time to think about buying. It’s true...

If you’re wanting to invest in the small side of the Australian share market, then the small caps listed below could be worth a closer look. Both of these shares have been named as buys and tipped for big things in the future. Here’s why t...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week There’s so...

ASX tech shares could be the right place to find opportunities in January 2022. There has been a lot of volatility over the last couple of months, with some businesses dropping (close) to multi-month lows. High-quality businesses that are...

2022 looks like a really good year to look at promising ASX growth shares. Plenty of attractive businesses have seen their share prices drop recently like Webjet Limited (ASX: WEB), Adore Beauty Group Ltd (ASX: ABY) and Temple & Webster...

It’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19 variants as they pop up. But with challenges, comes opportunities to learn and grow. So as the end of the year approaches, we took the chan...

It’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19 variants as they pop up. But with challenges, comes opportunities to learn and grow. So as the end of the year approaches, we took the chan...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been given buy ratings and tipped for big things in the future. Here’s what y...

It’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19 variants as they pop up. But with challenges, comes opportunities to learn and grow. So as the end of the year approaches, we took the chan...

It’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19 variants as they pop up. But with challenges, comes opportunities to learn and grow. So as the end of the year approaches, we took the chan...

Some ASX healthcare shares have been rated as buys for 2022 by experts. Healthcare companies have the potential of producing both growth and defensive earnings. People don’t choose when they get sick, and health is very important to most p...

Howdy Folks! We’re trying something new at Rask Media.  It’s called Rask bulls vs bears club.   Two writers will provide the bull and bear case for a popular company our readers are interested in On Friday you would have seen the Appen bull...

ASX growth shares increasing in size quickly could be contenders for an investor’s portfolio. There is growing volatility in the ASX share market. This may open up some better value opportunities for people to find. Share prices regularly...

ASX growth shares could be the perfect place to find some long-term opportunities in December 2021. Businesses that are seeing really quick growth of revenue have the potential to become much bigger in the coming years. I think that recent...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((FPH)) - Fisher & Paykel Healthcare ((SHV)) - Select Harvests ((TNE)) - TechnologyOne ((VHT)) - Volpara Health Technologies Check it out at https://www.fnarena.com/i...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

The Volpara Health Technologies Ltd (ASX: VHT) share price is rising after the healthcare business released its HY22 result. Volpara is a medical technology business which specialises in breast screening for cancer. The business also has a...

The Volpara Health Technologies Ltd (ASX: VHT) share price is in the green in early trade today, up 2.9% to $1.06. Investors are pushing up Volpara Health shares after the medical technology software as a service (SaaS) player released its...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week The Healthc...

If investors have got money to invest, then there could be some compelling ASX share ideas to consider for the long-term. Businesses that are displaying growth, or have plans for growth, could be worth considering. Here are two ASX shares...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been tipped for big things in the future. Here’s why these small cap ASX shar...